glp-1 anorexia Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders They Used GLP-1s to Lose

Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, et al

[10] [11] Small clinical trials of liraglutide in HFrEF (FIGHT and LIVE) have shown heart rate increases and potential safety signals, suggesting caution in this population

Pros : Cons: What your doctor might consider ZepBound (tirzepetide) is a newer, dual-agonist medication that targets more than one receptor in your body

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GIPR (rs1800437), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways

A head-to-head meta-analysis of GLP-1 medications across 16 studies (5,997 patients) found that Semaglutide significantly reduced HbA1c compared to Liraglutide (0.56